ArticleBMJ open2017
Haematological and electrophoretic characterisation of β-thalassaemia in Yunnan province of Southwestern China.
Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 18 citations in OpenAlex.
- Recent Advances in Thalassemia Research: A Comprehensive Assessment From Diagnostic Technologies to Clinical Treatment.Journal of clinical laboratory analysis · 2026Review
- Phenotypic Variability and Hematological Characterization of βJournal of clinical medicine research · 2025Article
- Case report: A rare heterozygous Hb CS with heterozygous HbE in a family with thalassemia in China.Heliyon · 2024Article
- Mutational analysis of hemoglobin genes and functional characterization of detected variants, through in-silico analysis, in Pakistani beta-thalassemia major patients.Scientific reports · 2023Article
- Article
- Therapeutic adenine base editing of human hematopoietic stem cells.Nature communications · 2023Article
- Detection of hemoglobin H disease by long molecule sequencing.Journal of clinical laboratory analysis · 2022Article
- Establishment of pregnant-specific intervals for hemoglobin (Hb) A2, HbF and cut-off points for HbA2 for thalassemia in Chongqing, China.Saudi medical journal · 2022Article
- Prevalence and molecular spectrum of α- and β-globin gene mutations in Hainan, China.International journal of hematology · 2021Article
- Molecular epidemiology, pathogenicity, and structural analysis of haemoglobin variants in the Yunnan province population of Southwestern China.Scientific reports · 2019Article
- Comparison between capillary zone electrophoresis and capillary isoelectric focusing for thalassemia screening in southern China.Journal of clinical laboratory analysis · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesβ-Thalassaemia is widely found in Southwestern China. Characterisation of β-thalassaemia can improve screening and prenatal diagnosis for at-risk populations.
designA retrospective study.
methodsIn this study, the levels of haemoglobin alpha 2 (HbA
resultsHbA levels were significantly higher in men than in women, but there was no significant difference on HbA
conclusionsEthnic groups have diversified β-globin gene mutations and considerable haematological variations. Our study will lay the foundation for screening programmes and clinical management of thalassaemia in Southwestern China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.